D2G Oncology
Founders
Jonathan MacQuitty, Ph.D. - CEO
Monte Winslow, Ph.D. - Co-founder
Dmitri Petrov, Ph.D. - co-founder
Ian Winters, Ph.D. - co-founder
Founded
2018
Stage
Seed
Invested
2018
Status
Private
Lightspeed Team
Jonathan MacQuitty - Partner

D2G Oncology leverages quantitative and multiplexed functional cancer genomics to relate drugs to genotypes to transform precision cancer therapeutics.

Jonathan MacQuitty
Fraction Fraction

Faction Ventures, LLC (“Faction”) and Lightspeed Management Company, L.L.C. (“Lightspeed”) are separate businesses that operate independently of each other. Faction is a registered investment adviser under the United States Investment Advisers Act of 1940, as amended. Faction advises its own fund(s) and does not advise any Lightspeed clients, and Lightspeed does not advise Faction or any of its clients. Lightspeed and Faction are parties to an agreement pursuant to which Lightspeed holds certain interests in Faction and the fund(s) Faction manages.

continue to the Faction Site